• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • GigaGen Initiates Large-Scale Manufacturing of GIGA-2050 contractpharma
    September 24, 2020
    ​GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, has initiated large-scale manufacturing of its recombinant hyperimmune drug for COVID-19 ...
  • GigaGen develops new class of drugs to treat Covid-19 pharmaceutical-technology
    August 11, 2020
    US-based biotechnology company GigaGen has developed a new class of drugs, called recombinant hyperimmunes, to potentially treat patients with Covid-19.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service